Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chromous sulfate is an inorganic compound with the formula CrSO4, representing the divalent (chromium(II)) form of chromium combined with sulfate. It is primarily used as a supplement in intravenous solutions for total parenteral nutrition (TPN) to maintain adequate serum chromium levels and prevent deficiency symptoms[1][2]. Chromium plays a role in normal glucose metabolism and peripheral nerve function by enhancing insulin binding to cells and improving glucose utilization[2][3]. Chromous sulfate itself is not widely used as a pharmaceutical agent but may be encountered as an analytical reagent or industrial chemical. Its mechanism of action relates to its ability to provide bioavailable trivalent chromium, which acts as a cofactor for insulin signaling pathways. Industrially, different forms of chromium sulfates are also used in tanning, dyeing, and other chemical processes[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chromous sulfate.